Patents by Inventor Anne Faure

Anne Faure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical dosage form
    Patent number: 9750701
    Abstract: The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: September 5, 2017
    Assignee: GRÜNENTHAL GMBH
    Inventors: Eugeen Marie Jozef Jans, Filip René Irena Kiekens, Jody Firmin Marceline Voorspoels, Anne Faure, Iris Ziegler, Elisabeth Arkenau-Maric, Lutz Barnscheid, Johannes Bartholomäus, Marc Frevel, Eric Galia, Andrea Schüessele
  • PHARMACEUTICAL DOSAGE FORM
    Publication number: 20160199305
    Abstract: The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
    Type: Application
    Filed: December 11, 2015
    Publication date: July 14, 2016
    Applicant: GRÜNENTHAL GMBH
    Inventors: EUGEEN MARIE JOZEF JANS, FILIP RENÉ IRENA KIEKENS, JODY FIRMIN MARCELINE VOORSPOELS, ANNE FAURE, IRIS ZIEGLER, ELISABETH ARKENAU-MARIC, LUTZ BARNSCHEID, JOHANNES BARTHOLOMÄUS, MARC FREVEL, ERIC GALIA, ANDREA SCHÜESSELE
  • FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES
    Publication number: 20150342926
    Abstract: The present invention is directed a pharmaceutical compositions for co-therapy treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 3, 2015
    Inventors: Urbain Alfons Clementina Delaet, Anne Faure, Philip Erna Hortentia Gilbert Heyns, Eugeen Maria Jozef Jans, Aniruddha Railkar
  • Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
    Patent number: 9161917
    Abstract: Process for preparing a powder comprising the steps of providing at least one first component in liquid form at ambient temperature, providing at least one second component having a melting point or melting range in the range from above ambient temperature to below the degradation temperature of said first component, forming a homogenous liquid mixture comprising the at least one first component and the at least one second component by stirring and heating the mixture to or keeping the mixture at a temperature in the range from above the melting point or melting range of the second component and below the degradation temperature of the first component, transferring the liquid mixture to at least one spray congealing unit, spray congealing the mixture, and isolating the powder obtained upon spray congealing.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: October 20, 2015
    Assignee: GRÜNENTHAL GMBH
    Inventors: Anne Faure, Jody Firim Marceline Voorspoels, Roel Jos M. Mertens, Filip René Irena Kiekens
  • PHARMACEUTICAL DOSAGE FORM
    Publication number: 20140322323
    Abstract: The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
    Type: Application
    Filed: April 25, 2014
    Publication date: October 30, 2014
    Applicant: GRÜNENTHAL GMBH
    Inventors: EUGEEN MARIE JOZEF JANS, FILIP RENÉ IRENA KIEKENS, JODY FIRMIN MARCELINE VOORSPOELS, ANNE FAURE, IRIS ZIEGLER, ELISABETH ARKENAU-MARIC, LUTZ BARNSCHEID, JOHANNES BARTHOLOMÄUS, MARC FREVEL, ERIC GALIA, ANDREA SCHÜESSELE
  • FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES
    Publication number: 20140302137
    Abstract: The present invention is directed a pharmaceutical compositions for co-therapy treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
    Type: Application
    Filed: June 20, 2014
    Publication date: October 9, 2014
    Inventors: Urbain Alfons Clementina Delaet, Anne Faure, Philip Erna Hortentia Gilbert Heyns, Eugeen Maria Jozef Jans, Aniruddha Railkar
  • Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
    Patent number: 8546428
    Abstract: The present invention relates to the fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol, pharmaceutical compositions comprising as active ingredient said salt and to processes for their preparation.
    Type: Grant
    Filed: December 3, 2007
    Date of Patent: October 1, 2013
    Assignee: Janssen Pharmaceutica NV
    Inventors: Jean François Alexandre Lucas Hegyi, Wim Albert Alex Aelterman, Yolande Lydia Lang, Sigrid Carl Maria Stokbroekx, Carina Leys, Peter Jozef Maria Van Remoortere, Anne Faure
  • PHARMACEUTICAL DOSAGE FORM
    Publication number: 20130251759
    Abstract: The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
    Type: Application
    Filed: January 16, 2013
    Publication date: September 26, 2013
    Applicant: GRUENENTHAL GMBH
    Inventors: EUGEEN MARIE JOZEF JANS, FILIP RENÉ IRENA KIEKENS, JODY FIRMIN MARCELINE VOORSPOELS, ANNE FAURE, IRIS ZIEGLER, ELISABETH ARKENAU-MARIC, LUTZ BARNSCHEID, JOHANNES BARTHOLOMUÄS, MARC FREVEL, ERIC GALIA, ANDREA SCHÜESSELE
  • Pharmaceutical dosage form
    Patent number: 8383152
    Abstract: The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: February 26, 2013
    Assignee: Gruenenthal GmbH
    Inventors: Eugeen Marie Jozef Jans, Filip René Irena Kiekens, Jody Firmin Marceline Voorspoels, Anne Faure, Elisabeth Arkenau-Maric, Lutz Barnscheid, Johannes Bartholomäus, Marc Frevel, Eric Galia, Iris Ziegler, Andrea Schüssele
  • FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES
    Publication number: 20120009259
    Abstract: The present invention is directed a pharmaceutical compositions for co-therapy treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
    Type: Application
    Filed: July 6, 2011
    Publication date: January 12, 2012
    Inventors: Urbain Alfons Clementina Delaet, Anne Faure, Philip Erna Hortentia Gilbert Heyns, Eugeen Maria Jozef Jans, Aniruddha Railkar
  • PROCESS FOR THE PREPARATION OF A SOLID DOSAGE FORM, IN PARTICULAR A TABLET, FOR PHARMACEUTICAL USE AND PROCESS FOR THE PREPARATION OF A PRECURSOR FOR A SOLID DOSAGE FORM, IN PARTICULAR A TABLET
    Publication number: 20110082214
    Abstract: Process for preparing a powder comprising the steps of providing at least one first component in liquid form at ambient temperature, providing at least one second component having a melting point or melting range in the range from above ambient temperature to below the degradation temperature of said first component, forming a homogenous liquid mixture comprising the at least one first component and the at least one second component by stirring and heating the mixture to or keeping the mixture at a temperature in the range from above the melting point or melting range of the second component and below the degradation temperature of the first component, transferring the liquid mixture to at least one spray congealing unit, spray congealing the mixture, and isolating the powder obtained upon spray congealing.
    Type: Application
    Filed: November 1, 2010
    Publication date: April 7, 2011
    Applicant: GRUENTHAL GMBH
    Inventors: Anne Faure, Jody Firim Marceline Voorspoels, Roel Jos M. Mertens, Filip René Irena Kiekens
  • FUMARATE SALT OF (ALPHA S, BETA R)-6-BROMO-ALPHA-[2-(DIMETHYLAMINO)ETHYL]-2-METHOXY-ALPHA-1-NAPHTHALENYL-BETA-PHENYL-3-QUINOLINEETHANOL
    Publication number: 20100028428
    Abstract: The present invention relates to the fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1 -naphthalenyl-beta-phenyl-3-quinolineethanol, pharmaceutical compositions comprising as active ingredient said salt and to processes for their preparation.
    Type: Application
    Filed: December 3, 2007
    Publication date: February 4, 2010
    Inventors: Jean Francois Alexandre Lucas Hegyi, Wim Albert Alex Aelterman, Yolande Lydia Lang, Sigrid Carl Maria Stokbroekx, Carina Leys, Peter Josef Maria Van Remoortere, Anne Faure
  • PHARMACEUTICAL DOSAGE FORM
    Publication number: 20090202634
    Abstract: The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
    Type: Application
    Filed: January 23, 2009
    Publication date: August 13, 2009
    Applicant: Grunenthal GmbH
    Inventors: Eugeen Marie Jozef JANS, Filip Rene Irena KIEKENS, Jody Firmin Marceline VOORSPOELS, Anne FAURE, Elisabeth ARKENAU-MARIC, Lutz BARNSCHEID, Johannes BARTHOLOMAUS, Marc FREVEL, Eric GALIA, Iris ZIEGLER